Cargando…
Platelet Carbonic Anhydrase II, a Forgotten Enzyme, May Be Responsible for Aspirin Resistance
BACKGROUND: Thromboembolic events constitute a major health problem, despite the steadily expanding arsenal of antiplatelet drugs. Hence, there is still a need to optimize the antiplatelet therapy. OBJECTIVES: The aim of our study was to verify a hypothesis that there are no differences in platelet...
Autores principales: | Jakubowski, M., Dębski, J., Szahidewicz-Krupska, E., Turek-Jakubowska, A., Gawryś, J., Gawryś, K., Skomro, R., Derkacz, A., Doroszko, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635279/ https://www.ncbi.nlm.nih.gov/pubmed/29090039 http://dx.doi.org/10.1155/2017/3132063 |
Ejemplares similares
-
Platelet-Derived Drug Targets and Biomarkers of Ischemic Stroke—The First Dynamic Human LC-MS Proteomic Study
por: Gawryś, Karolina, et al.
Publicado: (2022) -
New Candidates for Biomarkers and Drug Targets of Ischemic Stroke—A First Dynamic LC-MS Human Serum Proteomic Study
por: Turek-Jakubowska, Aleksandra, et al.
Publicado: (2022) -
The Human Carbonic Anhydrase II in Platelets: An Underestimated Field of Its Activity
por: Jakubowski, Maciej, et al.
Publicado: (2018) -
Interactions between the Cyclooxygenase Metabolic Pathway and the Renin-Angiotensin-Aldosterone Systems: Their Effect on Cardiovascular Risk, from Theory to the Clinical Practice
por: Gawrys, Jakub, et al.
Publicado: (2018) -
Increased Intraplatelet ADMA Level May Promote Platelet Activation in Diabetes Mellitus
por: Gawryś, Jakub, et al.
Publicado: (2020)